Trial intelligence / Profile preview

IMMUNE: High-Dose vs Standard-Dose Flu Vaccine in Young Cancer Patients

NCT01666782Phase 2Completed

Start
Aug 2012
Primary completion
Jun 2015
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of influenza virus vaccine, split virion in influenza. Started Aug 2012; status: completed.

02

Drugs

influenza virus vaccine, split virion
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01666782.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01666782.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call